Acute weakness associated with West Nile virus (WNV) infection has previously been attributed to a peripheral demyelinating process (Guillain-Barré syndrome); however, the exact etiology of this acute flaccid paralysis has not been systematically assessed. To thoroughly describe the clinical, laboratory, and electrodiagnostic features of this paralysis syndrome, we evaluated acute flaccid paralysis that developed in seven patients in the setting of acute WNV infection, consecutively identified in four hospitals in St. Tammany Parish and New Orleans, Louisiana, and Jackson, Mississippi. All patients had acute onset of asymmetric weakness and areflexia but no sensory abnormalities. Clinical and electrodiagnostic data suggested the involvement of spinal anterior horn cells, resulting in a poliomyelitis-like syndrome. In areas in which transmission is occurring, WNV infection should be considered in patients with acute flaccid paralysis. Recognition that such weakness may be of spinal origin may prevent inappropriate treatment and diagnostic testing.
Most human infections with West Nile virus (WNV), a flavivirus within the Japanese encephalitis virus antigenic complex, are clinically inapparent (
Seven patients were detected through WNV surveillance conducted by the Mississippi Department of Health and the Louisiana Office of Public Health. For each patient, a standardized questionnaire, including demographics, medical history, initial signs and symptoms, risk factors, and treatment, was completed; a standardized neurologic examination was performed by a single neurologist (JJS). Electrodiagnostic studies were performed by neurologists (AAL and JAVG) specializing in electrodiagnostic medicine.
Cerebrospinal fluid (CSF) and acute- or convalescent-phase serum specimens (or both) from each patient were tested for antibody to WNV by immunoglobulin (Ig) M antibody-capture enzyme immunoassay (
| IgM-capture enzyme immunoassay | Plaque reduction neutralization assay | ||||||
|---|---|---|---|---|---|---|---|
| Case | Onset | Collection | Sample | SLEV | WNV | SLEV | WNV |
| 1 | 6/24 | 7/12 | Serum | 3.5 | 22.3 | 320 | 5,120 |
| 2 | 7/12 | 7/16 | Serum | 8.0 | 22.7 | 80 | 1,280 |
| 3 | 7/26 | 8/1 | Serum | 2.79 | 24.9 | <10 | 640 |
| 4 | 7/29 | 8/3 | Serum | 1.1 | 14.1 | <10 | 80 |
| 4 | 7/29 | 8/3 | CSF | 3.3 | 39.2 | ||
| 4 | 7/29 | 8/13 | Serum | 4.4 | 23.5 | 40 | 2,560 |
| 5 | 8/11 | 8/15 | Serum | 2.02 | |||
| 5 | 8/11 | 8/29 | Serum | 3.4 | 25.7 | ||
| 6 | 8/13 | 8/16 | CSF | 6.1 | 23.8 | ||
| 6 | 8/13 | 8/16 | Serum | 1.0 | 5.7 | <10 | 40 |
| 7 | 9/1 | 10/24 | Serum | 2.8 | 10.6 | 10 | 320 |
| 7 | 9/1 | 9/6 | CSF | Not performed | 7.4 | ||
aIgM, immunoglobulin M; SLEV, Saint Louis encephalitis virus; CSF, cerebrospinal fluid.
All seven patients had serologic evidence of WNV infection (
On July 1, 2002, a previously healthy, 56-year-old, male Mississippi resident was hospitalized with a 1-week history of fever, chills, night sweats, myalgias, and acute encephalopathy. Neurologic examination showed profound weakness in both arms, asymmetric weakness in the legs with a right foot drop, and acute respiratory distress (
| Case no. | Fever
( | Headache | Nuchal rigidity | Altered mental status | Tremor | Distribution of weaknessa |
|---|---|---|---|---|---|---|
| 1 | + | + | + | + | + | Upper and lower limbs, R > L |
| 2 | + | + | - | + | - | Upper and lower limbs, R > L |
| 3 | + | - | - | - | + | Lower limbs, R > L |
| 4 | + | + | + | + | + | R upper limb |
| 5 | - | + | - | - | - | R upper limb |
| 6 | + | + | - | - | + | Lower limbs, R > L |
| 7 | + | + | + | - | - | Upper and lower limbs, L > R; bulbar muscles |
aR, right; L, left.
| Case no. | Leukocytes (x103/mm3) | Hematocrit (%) | CSF WBC (/mm3) | CSF RBC (/mm3) | CSF protein (mg/dL) | CSF glucose (mg/dL) |
|---|---|---|---|---|---|---|
| 1 | 17.6 | 38.0 | 3 | 1,778 | 89 | 54 |
| 2 | 3.6 | 38.2 | 2,600 | 87 | 204 | 99 |
| 3 | 11.8 | 44.4 | 140 | 40 | 234 | 74 |
| 4 | 9.5 | 37.8 | 143 | 4 | 116 | 119 |
| 5 | 7.9 | 45.6 | Not performed | Not performed | Not performed | Not performed |
| 6 | 13.0 | 45.4 | 329 | 7 | 75 | 66 |
| 7 | 10.3 | Not performed | 182 | 9 | 37 | 79 |
aCSF, cerebrospinal fluid; WBC, leukocyte count; RBC, erythrocyte count.
On July 15, 2002, a 57-year-old male Mississippi resident with a remote history of prostate cancer and glucose intolerance was hospitalized with a 3-day history of fever, chills, nausea, vomiting, and headache. Neurologic examination showed encephalopathy and asymmetric weakness in all limbs (
On July 24, 2002, a low-grade fever, nausea, and vomiting, followed by shaking chills and sweats, developed in a 56-year-old male Louisiana resident with a history of hypertension and coronary artery disease. The next day, asymmetric weakness developed in the lower extremities, with no pain or numbness. Upper extremities were normal. No bowel or bladder dysfunction was present. The patient was hospitalized on July 29, and neurologic examination showed a flaccid, areflexic right lower extremity and a weak left lower extremity with diminished reflexes. Results of strength and reflex testing of the upper extremities were normal. Sensory examination results were normal except for a mild decrease in sensitivity to pinprick, temperature, touch, and vibration in a stocking-and-glove distribution (i.e., distal arms and legs). A coarse bilateral upper extremity action tremor was noted. The patient had no headache, neck stiffness, or alteration of mental status (
MRI of the cervical, thoracic, and lumbosacral spine obtained during rehabilitation was notable for showing mild cervical and lumbosacral spinal stenosis and foraminal restrictions from C3 through C7 and homogeneous enhancement of the nerve roots of the cauda equina consistent with meningitis. Electrodiagnostic studies showed denervation in thoracic and lumbosacral myotomes, with no muscle activation in the right leg and reduced muscle activation in the left leg. CMAPs in the right leg were absent; SNAPs were normal. Electrodiagnostic findings suggested a severe, asymmetric process affecting anterior horn cells or motor axons. Diffuse axonal polyneuropathy was not evident, despite a slight sensory loss in the distal extremities.
On August 2, 2002, fever, headache, and neck stiffness developed in a 69-year-old female Louisiana resident with a history of diabetes and degenerative disc disease; the next day acute weakness occurred in the right arm without pain, numbness, or paresthesias. She was hospitalized on August 4. On admission, physical examination documented fever, vomiting, encephalopathy, nuchal rigidity, and a bilateral rash on the lower extremities. Neurologic examination displayed a flaccid and areflexic right arm. Her legs and left arm exhibited normal strength, reflexes, and coordination, with normal sensation in all limbs. A coarse tremor was noted in the chin, left arm, and legs (
On August 11, 2002, severe nausea, vomiting, headache, and diarrhea in the absence of fever developed in a 50-year-old male Mississippi resident with a history of alcohol abuse; the next day, progressive right arm weakness developed. He was hospitalized on August 14. Neurologic examination on admission showed flaccid paralysis of the right arm and mild weakness of the right leg, with normal sensation in all limbs (
On August 16, 2002, a 46-year-old male Louisiana resident with a history of coronary artery disease was hospitalized with fever, headache, fatigue, and leg weakness of 3 days’ duration. He reported no nuchal rigidity or mental status changes, although family members described him as intermittently confused. Neurologic examination showed a plegic and areflexic right leg and mild left leg weakness; sensation was intact throughout. A bilateral tremor of the upper extremities and jaw was noted (
On September 1, 2002, a previously healthy, 39-year-old male Louisiana resident had onset of fever, headache, and nuchal rigidity followed the next day by dysphagia and bilateral arm and leg weakness that was worse on the left. He was hospitalized on September 6 for acute respiratory failure and intubated. Neurologic examination showed normal cognition, asymmetric flaccid paralysis of the left arm and leg with absent reflexes, hyporeflexic weakness of the right arm and leg, and weakness of bulbar muscles (
The clinical and electrodiagnostic findings in these patients with WNV infection suggest involvement of spinal cord gray matter, specifically anterior horn cells, and a resulting acute poliomyelitis-like syndrome. All patients exhibited features typical for polio, including acute flaccid paralysis without paresthesias or sensory loss, marked asymmetric weakness, diminished or absent deep tendon reflexes in the affected limbs, and weakness that developed during an acute infectious process. Other typical features of poliomyelitis included CSF pleocytosis in five of six patients with CSF examination, acute respiratory distress in four, and acute changes in bowel or bladder function in two. In addition, electrodiagnostic findings showed asymmetric muscle denervation, reduced CMAPs, and preserved SNAPs. No patients had evidence of demyelinating polyneuropathy or myopathy. The absence of new sensory abnormalities localizes the disease process to the anterior horn cells or motor axons. Although muscle denervation and reduced CMAP amplitudes do not distinguish loss of anterior horn cells from loss of motor axons (
Since immunization has eradicated wild-type poliovirus from the developed world, most cases of paralytic polio-like conditions in the United States have been linked to other RNA viruses, including echoviruses, enteroviruses, and coxsackieviruses (
The assertion that WNV infection involves anterior horn cells and causes a polio-type syndrome has a pathologic basis. The neuropathology of experimental WNV infection in monkeys was most pronounced in the cerebellum, medulla, and the cervical and lumbar regions of the spinal cord (
Previous case studies have attributed WNV-associated acute flaccid paralysis to Guillain-Barré syndrome, motor axonopathy, or severe axonal polyneuropathy (
| Characteristic | West Nile virus–associated flaccid paralysis | Guillain-Barré syndrome |
|---|---|---|
| Timing of onset | Acute phase of infection | 1–8 weeks after acute infection |
| Fever and leukocytosis | Present | Absent |
| Weakness distribution | Asymmetric; occasional monoplegia | Generally symmetric; proximal and distal muscles |
| Sensory symptoms | Absence of numbness, paresthesias, or sensory loss; occasional myalgias | Painful distal paresthesias and sensory loss |
| Bowel/bladder involvement | Often present | Rare |
| Concurrent encephalopathy | Often present | Absent |
| CSF profile | Pleocytosis and elevated protein | No pleocytosis; elevated protein (albuminocytologic dissociation) |
| Electrodiagnostic features | Anterior horn cell/motor axon: reduced/absent CMAPs, preserved SNAPs; asymmetric denervation | Demyelination: marked slowing of conduction velocity; conduction block, temporal dispersion; reduced SNAPs |
aCSF, cerebrospinal fluid; CMAPs, compound muscle action potentials; SNAPSs, sensory nerve action potentials.
In Guillain-Barré syndrome, electrodiagnostic findings generally suggest peripheral nerve demyelination or, less commonly, a combined demyelinating and axonal process (
Three of the seven patients had acute flaccid paralysis without other findings, suggestive of severe central nervous system involvement caused by WNV infection. Physicians should suspect WNV infection in patients from areas where WNV is being transmitted and who have acute, painless, asymmetric weakness, even if unaccompanied by fever or apparent meningoencephalitis. Diagnostic studies should include testing for WNV-specific IgM antibody in CSF or acute- and convalescent-phase serum samples. In patients from such areas who have acute flaccid paralysis, CSF analysis, thorough electrodiagnostic studies, and spinal imaging should be considered before initiating diagnostic evaluations or therapies directed at Guillain-Barré syndrome, stroke, inflammatory myopathies, or other peripheral inflammatory processes. These therapies are ineffective for polio-like syndromes and can produce serious sequelae (
Continued surveillance and investigation of WNV-infected patients are needed to fully define the scope of clinical illness and determine the incidence of acute flaccid paralysis. In addition to assessing clinical outcome, the identification of risk factors and the pathologic confirmation of anterior horn cell involvement in patients with WNV-associated acute flaccid paralysis remain important public health goals.
We are grateful to Stanley W. Chapman, the Wilson Research Foundation, Raoult Ratard, Andrea Vicari, Grant L. Campbell, Michael Bunning, and Susan P. Montgomery for their important contributions to this investigation.
Dr. Sejvar is a neurologist and epidemiologist with the Centers for Disease Control and Prevention’s Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases. His current areas of research include the epidemiology of encephalitis, prion diseases, and other infections of the nervous system.